Stada Arzneimittel : From ugly duckling to market darling
Last year's € 250m subordinated bond issue was coolly received as investors reproached financial sponsors for their aggressiveness. The issue served indeed to fund a repurchase offer on minorities, together with € 705m of term loans with no equity contribution. Still, investors who bought into the issue have gained more than 13 pts thanks to the 7.25% of carry and 6% of price appreciation. - This time, the new € 760m senior issue (split between term loans and bonds) aimed at finan...Stada Arzneimittel is engaged in the development and marketing of products with off-patent active pharmaceutical ingredients in the health care and, in particular, in the pharmaceutical market. Generics is based on low pricing and/or a cross-product and cross-indication marketing concept while Branded Products focus on the specific product characteristics and, in particular, on the brand name of individual products. Co.'s business activities are divided into the four market regions of Germany, Central Europe, CIS / Eastern Europe and Asia & Pacific & Middle East / North Africa (MENA).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.